Home
Scholarly Works
ALKS 4230 monotherapy and in combination with...
Conference

ALKS 4230 monotherapy and in combination with pembrolizumab (pembro) in patients (pts) with refractory solid tumours (ARTISTRY-1)

Authors

Vaishampayan UN; Muzaffar J; Velcheti V; Winer I; Hoimes CJ; Rosen SD; Spreafico A; McDermott DF; Chu QS-C; Dumas O

Volume

31

Pagination

pp. s708-s709

Publisher

Elsevier

Publication Date

September 1, 2020

DOI

10.1016/j.annonc.2020.08.1147

Conference proceedings

Annals of Oncology

ISSN

0923-7534

Contact the Experts team